Get the Stockscreener App
1.94
8.06%
-0.17
Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News
Leerink Partnrs Has Pessimistic View of IRWD Q1 Earnings - MarketBeat
IRWD Shares Experience Decline in Value - Knox Daily
Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600 - MSN
Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600 By Investing.com - Investing.com Canada
STATE STREET CORP Reduces Stake in Ironwood Pharmaceuticals Inc - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 1-Year Low Following Analyst Downgrade - MarketBeat
Ironwood Pharmaceuticals Inc Inc. (IRWD) Price Performance: A Technical Analysis Perspective - The InvestChronicle
What was Ironwood Pharmaceuticals Inc (IRWD)’s performance in the last session? - US Post News
Leerink Partnrs Has Negative Estimate for IRWD Q4 Earnings - MarketBeat
JMP Securities Has Lowered Expectations for Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price - MarketBeat
Leerink Partnrs Brokers Lower Earnings Estimates for IRWD - Defense World
JMP Securities Cuts Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target to $14.00 - Defense World
Ironwood Pharmaceuticals Announces Workforce Reduction and Executive Appointment - Defense World
Leerink Partnrs Has Bearish Estimate for IRWD Q4 Earnings - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week Low After Analyst Downgrade - Defense World
Pacer Advisors Inc. Increases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Vanguard Group Inc Reduces Stake in Ironwood Pharmaceuticals Inc - GuruFocus.com
Investors irked by Ironwood cuts to future-proof company - The Pharma Letter
Ironwood focuses on apraglutide amid workforce cuts - MSN
Ironwood stock target cut to $14 by JMP Securities - MSN
Ironwood Pharmaceuticals stock tumbles following workforce cuts and revenue guidance - MSN
IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls - Yahoo Finance
Ironwood chops half of staff as 2025 guidance disappoints - PharmaLive
Ironwood Pharmaceuticals to Slash Half of Workforce, Drop Phase 2 Testing of Drug; Issues 2025 Outlook - Marketscreener.com
Ironwood Pharmaceuticals announces workforce reduction - MSN
Ironwood Pharma Announces Major Workforce Cuts and CFO Change - TipRanks
Ironwood Pharmaceuticals announces workforce reduction By Investing.com - Investing.com Nigeria
Ironwood Pharma drops 7% as FY 2025 revenue guidance below consensus - MSN
Ironwood Pharmaceuticals, Inc. Approves A Reduction in the Workforce of Approximately 50% - Marketscreener.com
Ironwood Pharmaceuticals, Inc. Announces Executive Changes -January 29, 2025 at 04:05 pm EST - Marketscreener.com
Analysts Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $10.00 - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 6.4% HigherStill a Buy? - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.00 Average Target Price from Brokerages - MarketBeat
Bladder Pain Syndrome Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Watson Pharma, Urigen, Allergan, Pfizer, Mundipharma Research GmbH, Ironwood Pharma, Astellas Pharma - The Globe and Mail
Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Lowered to $8.00 at Craig Hallum - MarketBeat
IRWD (Ironwood Pharmaceuticals) Cash From Discontinued Inve - GuruFocus.com
IRWD (Ironwood Pharmaceuticals) Net Income From Continuing Operations : $-3.1 Mil (TTM As of Sep. 2024) - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7%Should You Sell? - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Dips Amidst Market Volatility - GuruFocus.com
Short Bowel Syndrome Pipeline Trends 2024: Clinical Trials, Analysis of Clinical Trials, Therapies, MOA, ROA, and Developments by DelveInsight | Zealand Pharma, Ironwood Pharma, Hanmi Pharma, Shire - Barchart
Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock Position Reduced by Harbor Capital Advisors Inc. - Defense World
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Down -69.69% This Year: What Is Going To Happen Next - Stocks Register
Zacks Research Issues Optimistic Estimate for IRWD Earnings - Defense World
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2 - MSN
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 8.7%What's Next? - MarketBeat
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):